medigraphic.com
ISSN 1561-2945 (Print)

2013, Number 4

<< Back Next >>

Revista Cubana de Cirugía 2013; 52 (4)

Insulinoma, a propos of two cases

González GJL, González VJA, Pérez GD, Menéndez NJ, Abela LA

Language: Spanish
References: 17
Page: 287-295
PDF size: 387.37 Kb.


ABSTRACT

Insulinoma is the most common neuroendocrine pancreatic tumor. It manifests with adrenergic and neuroglycopenia signs. Its diagnosis is confirmed by documenting the existence of hypoglycemia together with inadequate insulin secretion. They developed from Langerhans islet cells and both functioning and non-functioning ones are embryologically and histologically very similar and just differ in their capacity to produce hormones or not. Here are two insulinoma cases where tumoral location was not possible with the conventional imaging techniques but with transoperative ultrasonography. The progression was favorable with total remission of symptoms.


REFERENCES

  1. Howard JM, Hess W. History of the pancreas: mysteries of a hidden organ. New York: Kluger Academic/Plenum Publishers; 2002.

  2. Whipple AO. Hyperinsulinism in relation to pancreatic tumors. Surgery 1944; 16: 289-305.

  3. Fernández-del Castillo C. Predicción de malignidad en neoplasias endocrinas del páncreas. Rev Invest Clin 2005; 57 (3): 481-487.

  4. Burgos L , Burgos de C. M E. Tumores neuroendocrinos del páncreas Rev Méd Chile 2004; 132: 627-634.

  5. Norton JA. Intraoperative methods to stage andlocalize pancreatic and duodenal tumors. AnnOncol1999; 10 Suppl 4: 182-4.

  6. Plokinger U, Wiewdenmann B. Neuroendocrine tumors of the gastro enteropancreatic system: The role of early diagnosis,genetic testing and preventive surgery. Dig Dis 2002; 20: 49-60.

  7. Brentjens R, Saltz L. Islet cell tumors of the pancreas: The medical oncologist's perspective. SurgClin North Am 2001; 81: 527-4

  8. Service FJ, McMahon MM, O'Brien PC, Ballard DJ.Functioninginsulinoma: incidence, recurrence, and longterm survival of patients: a 60-year study. Mayo ClinProc1991; 66: 711-9.

  9. Doherty GM. Pancreatic endocrine tumors. Problems in General Surgery. 2003; 20: 112-24.

  10. Miller J, Doherty GM. Tumores neuroendocrinos del páncreas. En: Burgos L (ed). Cirugía pancreática. Santiago: ArancibiaHnos y CíaLtda 2002; 176-90.

  11. PITRE J, SOUBRANE O, PALAZZO L, CHAPUIS Y. Endoscopic ultrasonography for the preoperative localization of insulinomas. Pancreas 1996; 13: 55-60.

  12. HASHIMOTO LA, WALSH RM. Preoperative localization of insulinomas is not necessary. J Am CollSurg 1999; 189: 368-73.

  13. MABRUT JY, LIFANTE JC, CHERKI S, SIN S, BERGER N, Is preoperative localization of insulinomas necessary? Ann Chir 2001; 126: 850.

  14. RaffelA, AnlaufM, HoschSB, KrauschM, HenoppT. Hyperinsulinemic hypoglycemia due to adult nesidioblastosisininsulin dependent diabetes. WorldJGastroenterol. 2006; 12:72214.

  15. Vezzosi D, Bennet A, Fauvel J, CaronP. Insulin C-peptideandproinsulin for the bio chemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol. 2007; 157:7583.

  16. Varas Lorenzo MJ. Manejo diagnostico del Insulinomapancreatico. Rev EspEnfermDig. 2008; 100:1845.

  17. Kovacs E, Nemeth H, Pasztor E, Pfliegler G. Hyperinsulinemic Hypoglycemia in adults. Case reports and short review. OrvHetil. 2008; 149:165964.




2020     |     www.medigraphic.com